GenesInk has changed its business model to speed up PE developments by proposing fine-tuned solutions and licensing contract which let to customer better TCO management.

This presentation will explain how this new business model is a game changer for the PE market by going through the following points :

• GenesInk as an externalized R&D center
• Partnership with technical centers
• Inks licensing